Navigation Links
Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting
Date:6/12/2009

-Company's New Name is PROLOR Biotech, Inc.-

-Will Now Trade under New Ticker PBTH-

-Shareholders Approve Re-Election of Board of Directors and Other Proposals-

NES-ZIONA, Israel, June 12 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today announced that shareholders approved a proposal to change the company's name to PROLOR Biotech, Inc. at its Annual Meeting of Shareholders held on May 21, 2009. The corporate name change became effective on Wednesday, June 10, 2009. Starting on Friday, June 12, 2009, the company's shares will trade on the OTC Bulletin Board under the symbol PBTH.

In addition to the new corporate name, shareholders re-elected all members of the company's Board of Directors, approved an amendment to the company's 2007 Equity Incentive Plan and ratified Yarel + Partners as the company's independent registered public accounting firm.

"Our new name, PROLOR Biotech--PROtein LOngevity Redefined--reflects our company's unique CTP technology that has been proven to significantly extend the longevity and biological activity of major therapeutic proteins such as follicle stimulating hormone, human growth hormone, interferon beta, erythropoietin, Factor VII and Factor IX, and potentially any other therapeutic protein," said Shai Novik, president of PROLOR Biotech. "It is fitting that we make this change now as we prepare to initiate our first clinical trial with our longer-acting version of human growth hormone, signalling our transformation into a clinical stage company."

ABOUT PROLOR BIOTECH

PROLOR Biotech, Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins, and PROLOR Biotech
'/>"/>

SOURCE PROLOR Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Modigene to Present at the Roth 2007 New York Investor Conference
2. Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
4. Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Modigene to Present at the UBS Global Life Sciences Conference
6. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
7. Modigene Sets Record Date for Annual Meeting of Shareholders
8. Modigene to Present at the BIO-Europe Spring(R) 2009 Conference
9. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
10. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
11. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... As a leading provider of telehealth ... release of their infographic - " 8 New ... goal was to leverage an information graphic to ... 3.0 and mHealth.The infographic features a list of ... the fitness industry in unimaginable ways; turning science ...
(Date:6/18/2013)... PathoGenetix, Inc. , a commercial-stage ... strain typing, announced today that John A. Luckey, ... President of Engineering. Dr. Luckey will lead technology ... Microbial Genotyping System . The fully automated RESOLUTION ... kits, database and software, will be commercially available ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Kitware ... today announces a new Fast-Track award from the U.S. ... design-analysis environment (IDAE) for the nuclear power industry. , ... for more than 30 years, but the United States’ ... remarkable gains in power plant utilization through improved refueling, ...
(Date:6/17/2013)... zuChem Inc., a leading producer of ... today that the United States Patent and Trademark ... 8,367,346 entitled “Methods for Production of Xylitol in ... D-Mannitol." These two patents expand zuChem's technology portfolio ... products from abundant, renewable feedstocks. , The ...
Breaking Biology Technology:MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2zuChem Receives Two Polyol Patents 2
... W.Va. Recent studies conducted at Marshall University have demonstrated ... used to increase the fuel efficiency of automobile engines -- ... this process is associated with liver damage. The ... his colleagues at Marshall,s Center for Diagnostic Nanosystems indicate there ...
... Nov. 17, 2011 Today BioSpace , the ... 2011-2012 BioForest™ Hotbed Campaign , marking the 7th ... The campaign highlights leading organizations across the ... is added to an electronic and printed campaign ...
... Builders, an award-winning general contractor specializing in a wide ... selected by the Los Angeles Biomedical Research Institute at ... of the initial phase for the creation of a ... 72-acre Harbor-UCLA Medical Center in Torrance, California.  Webcor will ...
Cached Biology Technology:Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver 2BioSpace Spotlights Northwest's Life Science Community 2Webcor Builders Selected as the General Contractor for First Phase of LA BioMed's New Campus Master Plan 2Webcor Builders Selected as the General Contractor for First Phase of LA BioMed's New Campus Master Plan 3
(Date:6/18/2013)... extract of a yellow-flowered mountain plant long used for ... fruit fly populations by an average of 24 percent, ... Rhodiola rosea , also known as ... study leaders Mahtab Jafari and Sam Schriner. They discovered ... unrelated to dietary restriction and affects different molecular pathways. ...
(Date:6/18/2013)... of Adelaide shows that weight gain and increased head size ... a higher IQ at early school age. , The study was ... from more than 13,800 children who were born full-term. , The ... that babies who put on 40% of their birthweight in the ... time they were six years of age, compared with babies who ...
(Date:6/17/2013)... LA JOLLA, CA June 17, 2013 An ... Institute (TSRI), the Howard Hughes Medical Institute and Albert ... a highly promising new anti-tuberculosis compound that attacks the ... findings represent an effort to help solve one of ... of TB and its dangerous drug-resistant strains," said Peter ...
Breaking Biology News(10 mins):Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2IQ link to baby's weight gain in first month 2New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4
... common cause of pain and disability and ... and hip fractures. Yet there is evidence that ... fractures in their patients. Even if the fractures ... The Vertebral Fracture Initiative, available at ...
... 9, 2011 MaxID Pty Ltd, a wholly owned company ... is pleased to announce that it has won a 1000-unit ... "MaxID, with its distribution partner, Pinnacle Technology Holdings Ltd Group, ... Africa market.  Our iDL500, which is an incredibly proven device ...
... researchers have designed a new tool for identifying protein ... Ekker, Ph.D., succeeded in switching individual genes off and ... The study appears in the journal Nature Methods ... health-related problems such as how cancerous cells spread, what ...
Cached Biology News:New IOF teaching tool helps health professionals identify vertebral fractures 2MaxID Lands Sale of 1000 iDL500 Multi-Modal Handheld Identity Devices in South Africa 2In a genetic research first, Mayo Clinic turns zebrafish genes off and on 2In a genetic research first, Mayo Clinic turns zebrafish genes off and on 3
15(S)-HETE-d8 is used as an internal standard for the quantification of 15(S)-HETE by stable isotope dilution mass spectrometry....
...
...
All-in-one mix, removes primers and dNTPs from PCR product for following direct sequencing...
Biology Products: